Health & Fitness

According to FutureWise analysis the market for Medication Error Reporting in 2023 was US$ 0.54 billion, and is expected to reach US$ 1.62 billion by 2031 at a CAGR of 14.72%. Medication errors are a significant and preventable source of patient harm, arising from mistakes made in the prescription, dispensing, or administration of medications. These errors can occur at any stage of medication use, from writing prescriptions to administering drugs, and they undermine patient trust in the healthcare system while increasing morbidity, mortality, and costs. Each year, the U.S. Food and Drug Administration (FDA) receives over 100,000 complaints about suspected medication errors. In response, the FDA is committed to enhancing patient safety by thoroughly reviewing drug names, labeling, packaging, and product design before approving medications for market. Through these efforts, we can work toward a safer healthcare environment for all. FutureWise Market Research has published a ... Continue reading →

According to Futurewise analysis, Medical Device Lighting Market was valued at USD 2.2 Mn in 2023 and is projected to reach a value of USD 3.5 Mn in 2032, and register a CAGR of 5.5% during the forecast period. This report analyzes the medical device lighting market, segmenting it based on product type, application, technology, and end users at a global level. The study provides insights into this market, highlighting technological trends, adoption rates, industry dynamics, and a competitive analysis of major players. The industry landscape includes a list of key market leaders, a Porter’s Five Forces analysis, a PESTLE analysis, and the key dynamics affecting the global medical device lighting market. These dynamics encompass factors driving market growth, existing challenges, potential opportunities, and future trends relevant to both global and regional contexts. Additionally, the study offers detailed profiles of the leading companies in the global medical device lighting ... Continue reading →

According to FutureWise analysis the market for mixed-mode chromatography resin in 2023 was US$ 0.11 billion, and is expected to reach US$ 0.2 billion by 2031 at a CAGR of 7.32%. Mixed-mode chromatography is an advanced separation technique that combines both ion exchange and hydrophobic interactions to effectively purify and separate biological molecules. The resin used in mixed-mode chromatography is specially designed to possess both ion-exchange and hydrophobic characteristics, enabling it to facilitate both types of chromatography simultaneously. This innovative approach has gained popularity, particularly for purifying proteins and other complex biological molecules that may pose challenges when using conventional methods like traditional ion exchange or hydrophobic interaction chromatography alone. The growing demand for effective drug development, especially in the search for treatments for contagious diseases such as Ebola, Zika, and H1N1, has been a driving ... Continue reading →

According to FutureWise analysis the market for platelet rich plasma is expected to register a CAGR of 15.30% from 2024-2032. Platelets are specialized blood cells generated in the bone marrow alongside white and red blood cells. Their primary function is to facilitate the formation of blood clots, thereby preventing excessive bleeding. The typical platelet count in a microliter of blood ranges from 150,000 to 450,000. To produce platelet-rich plasma (PRP), a small sample of the patient’s blood is obtained and subjected to centrifugation, which separates the platelets from the other components of blood. This concentrated platelet solution is then directly injected into the affected area. The process of centrifugation is essential for distinguishing between blood cells and plasma, resulting in a substance rich in platelets and plasma proteins. PRP has a wide array of applications, including its utilization in promoting hair growth and reducing inflammation. PRP is applicable in ... Continue reading →

According to FutureWise analysis, the market for immuno-oncology in 2023 was US$ 101.4 billion and is expected to reach US$ 240 billion by 2031 at a CAGR of 12%. Cancer immunotherapy, commonly referred to as immuno-oncology, represents a groundbreaking approach to cancer treatment that harnesses the body's own immune system to intercept, eliminate, and manage the disease. By enhancing immune responses, providing components that amplify the body's natural defenses, and training the immune system to identify and combat specific cancer cells, immunotherapy is a powerful tool in the fight against cancer. There are various immunotherapy modalities, including targeted antibodies, cancer vaccines, adoptive cell transfer, tumor-infecting viruses, checkpoint inhibitors, cytokines, and adjuvants. These therapies aim to either stimulate the immune system directly or provide it with the necessary tools to better identify and destroy cancer cells. As a subset of biotherapy (also known as ... Continue reading →

According to FutureWise analysis the market for GI stool testing in 2023 is US$ 1.03 billion, and is expected to reach US$ 1.6 billion by 2031 at a CAGR of 7.1%. GI stool testing is a diagnostic process that involves analyzing fecal samples to detect intestinal infections or diseases. This testing is crucial for identifying various gastrointestinal (GI) disorders, including bowel inflammation, malabsorption, and cancer. The rising incidence of GI diseases, driven by factors such as increased consumption of junk food, fast-paced lifestyles, and an aging population, is fueling growth in the GI stool testing market. As more individuals face gastrointestinal infections, both public and private sectors are anticipated to ramp up investments in healthcare, contributing further to market expansion. Numerous studies have established a link between gut health and overall well-being, highlighting the significant role that gut microbiota plays in mediating the effects of nutrition and ... Continue reading →

According to FutureWise analysis, the market for Ambulatory Blood Pressure Monitoring Devices is expected to reach US$ 0.31 billion by 2031 at a CAGR of 6.9% over the forecast period of 2023-2031. Ambulatory Blood Pressure Monitoring (ABPM) devices are advanced medical tools designed to measure a person's blood pressure over an extended period, typically 24 hours. Unlike standard blood pressure monitors that provide single readings taken at specific times, ABPM devices offer continuous and automatic monitoring of blood pressure throughout the day and night. This technology allows healthcare professionals to obtain a comprehensive and accurate profile of a patient's blood pressure fluctuations, offering valuable insights into their cardiovascular health. Key features of ABPM devices include their non-invasive and portable design, enabling patients to maintain their regular routines without disruption while wearing the monitoring equipment. Additionally, continuous monitoring ... Continue reading →

According to FutureWise analysis, the Combo IVD Market in 2024 was US$ 583 million and is expected to reach US$ 913 billion by 2032 at a CAGR of 6.23%. Combo in vitro diagnostics (IVDs) are changing how we take care of our health. These important medical tools examine samples from our bodies in a lab setting, giving us valuable information to help spot and track various health issues, from infections to autoimmune diseases. By combining multiple tests into one process, combo IVDs improve the accuracy of diagnoses and make healthcare more efficient. This means doctors can get the information they need faster, leading to better outcomes for patients. As technology continues to advance, these diagnostics are likely to lead to more personalized treatments, ensuring that care is specifically suited to each individual's needs. As global health challenges grow, particularly with the alarming rise in chronic diseases like diabetes, cancer, heart disease, and tuberculosis, the demand for ... Continue reading →

According to FutureWise analysis the market for gonorrhea therapeutics in 2023 was US$ 1.7 billion, and is expected to reach US$ 2.5 billion by 2031 at a CAGR of 5.3%. The bacterium *Neisseria gonorrhoeae* is responsible for the sexually transmitted disease gonorrhea. This infection commonly affects warm, moist areas of the body, including the urethra, eyes, throat, vagina, anus, and female reproductive tract. Gonorrhea is primarily transmitted through unprotected sexual intercourse. If a mother is infected, she can also pass the infection to her baby during delivery. Symptoms typically appear between two to fourteen days after exposure; however, some individuals may not exhibit any noticeable symptoms at all. Those without symptoms are at a higher risk of transmitting the infection to others. Due to its ability to quickly develop resistance to various antibiotic classes, gonococcal infections have become a significant global health concern. Over time, the effectiveness of antibiotics ... Continue reading →

According to FutureWise analysis the market for Cardiac Diagnostic Testing Devices in 2023 was US$ 16.48 billion, and is expected to reach US$ 29.87 billion by 2031 at a CAGR of 7.70%. The Cardiac Diagnostic Testing Devices Market represents a significant domain that provides critical insights into the electrical activity and rhythm of the heart, along with its efficacy in facilitating blood circulation through its chambers and valves. Furthermore, it plays a vital role in analyzing blood flow within the coronary arteries and detecting potential tumors or abnormalities within the cardiovascular system. Through comprehensive laboratory assessments, key risk factors for heart diseases can be identified by evaluating blood levels of fats, cholesterol, and lipids, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. Additionally, the monitoring of blood glucose levels and glycosylated hemoglobin is essential for the detection of diabetes, while ... Continue reading →